Construction of a Prognostic and Early Diagnosis Model for LUAD Based on Necroptosis Gene Signature and Exploration of Immunotherapy Potential.

Zhang, Baizhuo; Wang, Yudong; Zhou, Xiaozhu; Zhang, Zhen; Ju, Haoyu; Diao, Xiaoqi; Wu, Jiaoqi; Zhang, Jing

Zhang, Baizhuo; Wang, Yudong; Zhou, Xiaozhu; Zhang, Zhen; Ju, Haoyu; Diao, Xiaoqi; Wu, Jiaoqi; Zhang, Jing.

Afiliação

Zhang B; Department of Pharmacology, College of Pharmacy, China Medical University, Shenyang 110122, China.
Wang Y; Thoracic Surgery Department, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Zhou X; Department of Pharmacology, College of Pharmacy, China Medical University, Shenyang 110122, China.
Zhang Z; Department of Pharmacology, College of Pharmacy, China Medical University, Shenyang 110122, China.
Ju H; Department of Pharmacology, College of Pharmacy, China Medical University, Shenyang 110122, China.
Diao X; Department of Pharmacology, College of Pharmacy, China Medical University, Shenyang 110122, China.
Wu J; Department of Pharmacology, College of Pharmacy, China Medical University, Shenyang 110122, China.
Zhang J; Department of Pharmacology, College of Pharmacy, China Medical University, Shenyang 110122, China.

Cancers (Basel) ; 14(20)2022 Oct 20.

Article em En | MEDLINE | ID: mdl-36291937

Palavras-chave

biomarker; drug sensitivity; immune checkpoint; immune microenvironment; lung adenocarcinoma; necroptosis; prognostic and diagnostic; tumor immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google